BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26841933)

  • 21. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study.
    Makrythanasis P; van Bon BW; Steehouwer M; Rodríguez-Santiago B; Simpson M; Dias P; Anderlid BM; Arts P; Bhat M; Augello B; Biamino E; Bongers EM; Del Campo M; Cordeiro I; Cueto-González AM; Cuscó I; Deshpande C; Frysira E; Izatt L; Flores R; Galán E; Gener B; Gilissen C; Granneman SM; Hoyer J; Yntema HG; Kets CM; Koolen DA; Marcelis Cl; Medeira A; Micale L; Mohammed S; de Munnik SA; Nordgren A; Psoni S; Reardon W; Revencu N; Roscioli T; Ruiterkamp-Versteeg M; Santos HG; Schoumans J; Schuurs-Hoeijmakers JH; Silengo MC; Toledo L; Vendrell T; van der Burgt I; van Lier B; Zweier C; Reymond A; Trembath RC; Perez-Jurado L; Dupont J; de Vries BB; Brunner HG; Veltman JA; Merla G; Antonarakis SE; Hoischen A
    Clin Genet; 2013 Dec; 84(6):539-45. PubMed ID: 23320472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.
    Karagianni P; Lambropoulos V; Stergidou D; Fryssira H; Chatziioannidis I; Spyridakis I
    Am J Med Genet A; 2016 May; 170A(5):1333-8. PubMed ID: 26898171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes.
    Lintas C; Persico AM
    Clin Genet; 2018 Oct; 94(3-4):283-295. PubMed ID: 28139835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.
    Murakami H; Tsurusaki Y; Enomoto K; Kuroda Y; Yokoi T; Furuya N; Yoshihashi H; Minatogawa M; Abe-Hatano C; Ohashi I; Nishimura N; Kumaki T; Enomoto Y; Naruto T; Iwasaki F; Harada N; Ishikawa A; Kawame H; Sameshima K; Yamaguchi Y; Kobayashi M; Tominaga M; Ishikiriyama S; Tanaka T; Suzumura H; Ninomiya S; Kondo A; Kaname T; Kosaki K; Masuno M; Kuroki Y; Kurosawa K
    Am J Med Genet A; 2020 Oct; 182(10):2333-2344. PubMed ID: 32803813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.
    Aref-Eshghi E; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Rodenhiser D; Schwartz C; Sadikovic B
    Epigenetics; 2017; 12(11):923-933. PubMed ID: 28933623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth charts in Kabuki syndrome 1.
    Ruault V; Corsini C; Duflos C; Akouete S; Georgescu V; Abaji M; Alembick Y; Alix E; Amiel J; Amouroux C; Barat-Houari M; Baumann C; Bonnard A; Boursier G; Boute O; Burglen L; Busa T; Cordier MP; Cormier-Daire V; Delrue MA; Doray B; Faivre L; Fradin M; Gilbert-Dussardier B; Giuliano F; Goldenberg A; Gorokhova S; Héron D; Isidor B; Jacquemont ML; Jacquette A; Jeandel C; Lacombe D; Le Merrer M; Sang KHLQ; Lyonnet S; Manouvrier S; Michot C; Moncla A; Moutton S; Odent S; Pelet A; Philip N; Pinson L; Reversat J; Roume J; Sanchez E; Sanlaville D; Sarda P; Schaefer E; Till M; Touitou I; Toutain A; Willems M; Gatinois V; Geneviève D
    Am J Med Genet A; 2020 Mar; 182(3):446-453. PubMed ID: 31876365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kabuki syndrome as a cause of non-immune fetal hydrops/ascites.
    Long A; Sinkovskaya ES; Edmondson AC; Zackai E; Schrier Vergano SA
    Am J Med Genet A; 2016 Dec; 170(12):3333-3337. PubMed ID: 27568880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.
    Schott DA; Stumpel CTRM; Klaassens M
    Am J Med Genet A; 2019 Feb; 179(2):219-223. PubMed ID: 30556359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal and perinatal history in Kabuki Syndrome.
    Rosenberg CE; Daly T; Hung C; Hsueh I; Lindsley AW; Bodamer O
    Am J Med Genet A; 2020 Jan; 182(1):85-92. PubMed ID: 31654559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autism spectrum disorder in Kabuki syndrome: clinical, diagnostic and rehabilitative aspects assessed through the presentation of three cases.
    Parisi L; Di Filippo T; Roccella M
    Minerva Pediatr; 2015 Aug; 67(4):369-75. PubMed ID: 26129805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.
    Wang Y; Li N; Su Z; Xu Y; Liu S; Chen Y; Li X; Shen Y; Hung C; Wang J; Wang X; Bodamer O
    Am J Med Genet A; 2020 Apr; 182(4):640-651. PubMed ID: 31883305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype.
    Usluer E; Sayın GY; Güneş N; Kasap B; Tüysüz B
    Am J Med Genet A; 2022 Oct; 188(10):2976-2987. PubMed ID: 36097644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three generation X-linked family with Kabuki syndrome phenotype and a frameshift mutation in KDM6A.
    Lederer D; Shears D; Benoit V; Verellen-Dumoulin C; Maystadt I
    Am J Med Genet A; 2014 May; 164A(5):1289-92. PubMed ID: 24664873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [One novel pathologic variation in
    Qiu SW; Yuan YY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
    [No Abstract]   [Full Text] [Related]  

  • 35. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.
    Shangguan H; Su C; Ouyang Q; Cao B; Wang J; Gong C; Chen R
    Orphanet J Rare Dis; 2019 Nov; 14(1):255. PubMed ID: 31727177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo exonic deletion of KDM6A in a Chinese girl with Kabuki syndrome: A case report and brief literature review.
    Yang P; Tan H; Xia Y; Yu Q; Wei X; Guo R; Peng Y; Chen C; Li H; Mei L; Huang Y; Liang D; Wu L
    Am J Med Genet A; 2016 Jun; 170(6):1613-21. PubMed ID: 27028180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging in Kabuki syndrome and another KMT2D-related disorder.
    Stadelmaier RT; Kenna MA; Barrett D; Mullen TE; Bodamer O; Agrawal PB; Robson CD; Wojcik MH
    Am J Med Genet A; 2021 Dec; 185(12):3770-3783. PubMed ID: 34369642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.
    Bögershausen N; Tsai IC; Pohl E; Kiper PÖ; Beleggia F; Percin EF; Keupp K; Matchan A; Milz E; Alanay Y; Kayserili H; Liu Y; Banka S; Kranz A; Zenker M; Wieczorek D; Elcioglu N; Prontera P; Lyonnet S; Meitinger T; Stewart AF; Donnai D; Strom TM; Boduroglu K; Yigit G; Li Y; Katsanis N; Wollnik B
    J Clin Invest; 2015 Sep; 125(9):3585-99. PubMed ID: 26280580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the significance of craniosynostosis in a case of Kabuki syndrome with a concomitant KMT2D mutation and 3.2 Mbp de novo 10q22.3q23.1 deletion.
    Topa A; Samuelsson L; Lovmar L; Stenman G; Kölby L
    Am J Med Genet A; 2017 Aug; 173(8):2219-2225. PubMed ID: 28590022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.